Jared D. Acoba

Also affiliated with Queen's Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.271Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 16 papers — median percentile 21. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2023.50844

N/A

0.978DataRank · unranked

33 citations

Fenghai Duan, Na An, Ilanan F. Gareen, JoRean D. Sicks, Gelareh Sadigh +12 more

Financial Hardship Among Patients With Early-Stage Colorectal Cancer

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.31967

N/A

0.696DataRank · unranked

13 citations

Fenghai Duan, Na An, Ilana D. Gareen, JoRean D. Sicks, Jennifer M. Suga +13 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of Oncology(2023)10.1016/j.annonc.2023.10.047

N/A

0.500DataRank · unranked

27 citations

Susan M. Geyer, F-S. Ou, Michael V. Knopp, Spencer C. Behr, Tyler Zemla +14 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Obesity’s Disparate Impact on COVID-19 Outcomes in Asian American Patients with Cancer

medRxiv(2025)10.1101/2025.05.14.25327577

N/A

0DataRank · unranked

0 citations

Pankil Shah, Sanjay Mishra, Julie Fu, Sonya Reid, Jessica E. Hawley +18 more

Transarterial Radioembolization for Hepatocellular Carcinoma with Major Vascular Invasion: A Nationwide Propensity Score–Matched Analysis with Target Trial Emulation

Journal of Vascular and Interventional Radiology(2021)10.1016/j.jvir.2021.07.001

N/A

0DataRank · unranked

10 citations

Linda L. Wong, Miles M. Sato, Jared D. Acoba, Young Soo Rho, Avantika Srivastava +2 more

Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: Early results of ECOG-ACRIN EAQ162CD.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1518

N/A

0DataRank · unranked

0 citations

Fenghai Duan, Ilana F. Gareen, Ellen Underwood, JoRean D. Sicks, Jennifer M. Suga +7 more

Longitudinal changes in financial burden in patients with colorectal cancer treated with curative intent: Primary results of EAQ162CD.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6597

N/A

0DataRank · unranked

1 citations

Fenghai Duan, Ellen Underwood, Ilana F. Gareen, JoRean D. Sicks, Gelareh Sadigh +11 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Racial and Survival Disparities in Inflammatory Breast Cancer (IBC) and non-IBC: A Population-Based Study Focused on Native Hawaiians and Other Pacific Islanders

Research Square(2023)10.21203/rs.3.rs-3143571/v1

N/A

0DataRank · unranked

0 citations

Kyle Miyazaki, Jared D. Acoba, Takeo Fujii, Gene T. Yoshikawa

Racial and survival disparities in inflammatory breast cancer (IBC) and non-IBC: a population-based study focused on Native Hawaiians and other Pacific Islanders

Frontiers in Oncology(2024)10.3389/fonc.2024.1390080

N/A

0DataRank · unranked

6 citations

Kyle Miyazaki, Jared D. Acoba, Takeo Fujii, Gene T. Yoshikawa

1712P Efficacy and safety of cabozantinib (CABO) for advanced lung and thymic neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of phase III CABINET Trial (Alliance A021602)

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2340

N/A

0DataRank · unranked

1 citations

T. Zemla, Susan M. Geyer, Jonathan Strosberg, Þorvarður R. Hálfdánarson, Nikolaos A. Trikalinos +13 more

Jared D. Acoba

Indexed papers

Top data-sharing exemplar

Papers